JFC Technologies

JFC Technologies is a contract development and manufacturing organization (CDMO) based in Bound Brook, New Jersey, specializing in the custom synthesis of complex organic molecules and active pharmaceutical ingredients (APIs). The company provides a comprehensive suite of services including process research and development, analytical method development, and cGMP-compliant manufacturing for the pharmaceutical and biotechnology industries. Their expertise spans from laboratory-scale synthesis to pilot plant and commercial production, with a focus on sophisticated small molecule chemistry. In May 2021, JFC Technologies was acquired by Barentz, a global life science ingredients distributor, to bolster its specialty chemical and technical service offerings in North America. The company continues to support clients through various stages of drug development by providing scalable manufacturing solutions and regulatory support.